Siemens receives FDA approval for Xprecia Stride coagulation analyzer
Siemens announced FDA 510k clearance for a hand-held portable coagulation analyzer. The Xprecia Stride Coagulation Analyzer delivers fast, reliable Prothrombin Time International Normalized Ratio testing for point-of-care monitoring and management of oral anticoagulation therapy with warfarin, a vitamin K antagonist. "Among the many challenges of point of care testing, accuracy and safety have become paramount to both the user and patient. With the Xprecia Stride analyzer, Siemens Healthineers delivers on the promise to bring a safe and lab-accurate test directly to the patient," said Michael Sampson, Senior Vice President, Point of Care, Siemens Healthineers, North America. "The Xprecia Stride analyzer is designed to be safe, efficient and ergonomically friendly. By adding the Xprecia Stride analyzer to our existing product portfolio in the U.S., we now have the ability to cover the full range of hemostasis testing from the hospital lab to the physician's office."